Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

ARCHIT ORGANOSYS 2021-22 Annual Report Analysis
Wed, 24 Aug

ARCHIT ORGANOSYS has announced its results for the year ended March 2022. Let us have a look at the detailed performance review of the company during FY21-22.

ARCHIT ORGANOSYS Income Statement Analysis

  • Operating income during the year rose 44.6% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 45.3% YoY during the fiscal. Operating profit margins witnessed a fall and down at 11.8% in FY22 as against 11.7% in FY21.
  • Depreciation charges increased by 27.8% and finance costs decreased by 24.7% YoY, respectively.
  • Other income grew by 359.7% YoY.
  • Net profit for the year grew by 64.4% YoY.
  • Net profit margins during the year grew from 5.3% in FY21 to 6.0% in FY22.

ARCHIT ORGANOSYS Income Statement 2021-22

No. of Mths Year Ending 12 Mar-21* 12 Mar-22* % Change
Net Sales Rs m 945 1,367 44.6%
Other income Rs m 5 25 359.7%
Total Revenues Rs m 951 1,392 46.4%
Gross profit Rs m 111 161 45.3%
Depreciation Rs m 37 47 27.8%
Interest Rs m 33 24 -24.7%
Profit before tax Rs m 47 114 143.9%
Tax Rs m -3 32 NA
Profit after tax Rs m 50 82 64.4%
Gross profit margin % 11.7 11.8
Effective tax rate % -6.9 28.0
Net profit margin % 5.3 6.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Don't Miss: Key Information for Long-term Investors

ARCHIT ORGANOSYS Balance Sheet Analysis

  • The company's current liabilities during FY22 stood at Rs 394 million as compared to Rs 346 million in FY21, thereby witnessing an increase of 14.1%.
  • Long-term debt stood at Rs 122 million as compared to Rs 121 million during FY21, a growth of 0.8%.
  • Current assets rose 30% and stood at Rs 448 million, while fixed assets rose 17% and stood at Rs 606 million in FY22.
  • Overall, the total assets and liabilities for FY22 stood at Rs 1 billion as against Rs 864 million during FY21, thereby witnessing a growth of 22%.

ARCHIT ORGANOSYS Balance Sheet as on March 2022

No. of Mths Year Ending 12 Mar-21* 12 Mar-22* % Change
Networth Rs m 392 519 32.5
 
Current Liabilities Rs m 346 394 14.1
Long-term Debt Rs m 121 122 0.8
Total Liabilities Rs m 864 1,054 22.0
 
Current assets Rs m 345 448 29.9
Fixed Assets Rs m 519 606 16.7
Total Assets Rs m 864 1,054 22.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



ARCHIT ORGANOSYS Cash Flow Statement Analysis

  • ARCHIT ORGANOSYS's cash flow from operating activities (CFO) during FY22 stood at Rs 106 million on a YoY basis.
  • Cash flow from investing activities (CFI) during FY22 stood at Rs -115 million, an improvement of 301.7% on a YoY basis.
  • Cash flow from financial activities (CFF) during FY22 stood at Rs 24 million, an improvement of 133% on a YoY basis.
  • Overall, net cash flows for the company during FY22 stood at Rs 15 million from the Rs 9 million net cash flows seen during FY21.

ARCHIT ORGANOSYS Cash Flow Statement 2021-22

Particulars No. of months 12 12 % Change
Year Ending Mar-21 Mar-22
Cash Flow from Operating Activities Rs m 111 106 -4.4%
Cash Flow from Investing Activities Rs m -29 -115 -
Cash Flow from Financing Activities Rs m -74 24 -
Net Cash Flow Rs m 9 15 78.2%
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for ARCHIT ORGANOSYS

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 4.0, an improvement from the EPS of Rs 3.3 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 64.0, stands at 13.9 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 2.5 times, while the price to sales ratio stands at 1.0 times.
  • The company's price to cash flow (P/CF) ratio stood at 6.7 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-21* 12 Mar-22*
Sales per share (Unadj.) Rs 62.9 66.6
TTM Earnings per share Rs 3.3 4.0
Diluted earnings per share Rs 2.4 4.0
Price to Cash Flow x 5.9 6.7
TTM P/E ratio x 10.1 13.9
Price / Book Value ratio x 0.6 1.7
Market Cap Rs m 244 863
Dividends per share (Unadj.) Rs 0.0 0.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for ARCHIT ORGANOSYS

  • Solvency Ratios
  • Current Ratio: The company's current ratio improved and stood at 1.1x during FY22, from 1.0x during FY21. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 5.7x during FY22, from 2.4x during FY21. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company improved and stood at 15.9% during FY22, from 12.8% during FY22. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 21.6% during FY22, from 15.5% during FY21. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company improved and stood at 10.1% during FY22, from 9.6% during FY21. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-21* 12 Mar-22*
Current ratio x 1.0 1.1
Debtors’ Days Days 966 731
Interest coverage x 2.4 5.7
Debt to equity ratio x 0.3 0.2
Return on assets % 9.6 10.1
Return on equity % 12.8 15.9
Return on capital employed % 15.5 21.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how ARCHIT ORGANOSYS has performed over the last 5 years, please visit here.

ARCHIT ORGANOSYS Share Price Performance

Over the last one year, ARCHIT ORGANOSYS share price has moved up from Rs 42.6 to Rs 64.0, registering a gain of Rs 21.4 or around 50.2%.

Overall, the S&P BSE SENSEX is up 6.4% over the year.

(To know more, check out historical annual results for ARCHIT ORGANOSYS and quarterly results for ARCHIT ORGANOSYS)

Annual Report FAQs

What is the current share price of ARCHIT ORGANOSYS?

ARCHIT ORGANOSYS currently trades at Rs 43.9 per share. You can check out the latest share price performance of ARCHIT ORGANOSYS here...

What was the revenue of ARCHIT ORGANOSYS in FY22? How does it compare to earlier years?

The revenues of ARCHIT ORGANOSYS stood at Rs 1,392 m in FY22, which was up 46.4% compared to Rs 951 m reported in FY21.

ARCHIT ORGANOSYS' revenue has grown from Rs 842 m in FY18 to Rs 1,392 m in FY22.

Over the past 5 years, the revenue of ARCHIT ORGANOSYS has grown at a CAGR of 13.4%.

What was the net profit of ARCHIT ORGANOSYS in FY22? How does it compare to earlier years?

The net profit of ARCHIT ORGANOSYS stood at Rs 82 m in FY22, which was up 64.4% compared to Rs 50 m reported in FY21.

This compares to a net loss of Rs -8 m in FY20 and a net loss of Rs -47 m in FY19.

Over the past 5 years, ARCHIT ORGANOSYS net profit has grown at a CAGR of 100.5%.

What does the cash flow statement of ARCHIT ORGANOSYS reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of ARCHIT ORGANOSYS reveals:

  • Cash flow from operations decreased in FY22 and stood at Rs 106 m as compared to Rs 111 m in FY21.
  • Cash flow from investments decreased in FY22 and stood at Rs -115 m as compared to Rs -29 m in FY21.
  • Cash flow from financial activity increased in FY22 and stood at Rs 24 m as compared to Rs -74 m in FY21.

Here's the cash flow statement of ARCHIT ORGANOSYS for the past 5 years.

(Rs m)FY18FY19FY20FY21FY22
From Operations-382777111106
From Investments-9411-8-29-115
From Financial Activity1344-89-7424
Net Cashflow242-20915

What does the Key Ratio analysis of ARCHIT ORGANOSYS reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of ARCHIT ORGANOSYS reveals:

  • Operating profit margins witnessed a fall and down at 11.8% in FY22 as against 11.7% in FY21.
  • Net profit margins grew from 5.3% in FY21 to 6.0% in FY22.
  • Debt to Equity ratio for FY22 stood at 0.2 as compared to 0.3 in FY21.

Here's the ratio/financial analysis of ARCHIT ORGANOSYS for the past 5 years.

 FY18FY19FY20FY21FY22
Operating Profit Margin (%)4.9-3.64.711.711.8
Net Profit Margin (%)0.6-5.6-1.05.36.0
Debt to Equity Ratio (x)0.50.50.40.30.2

Equitymaster requests your view! Post a comment on "ARCHIT ORGANOSYS 2021-22 Annual Report Analysis". Click here!